Antenatal Corticosteroids Safe for Child Development
METHODOLOGY:
Researchers conducted a systematic review and meta-analysis of 14 studies, comprising eight randomized controlled trial follow-up studies (n = 2233) and six quasi-experimental studies (n = 277,679).
Analysis utilized random-effects meta-analyses to synthesize outcomes based on blinded adjudication of appropriateness for pooling by clinical experts in child neurodevelopment.
Investigators evaluated the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation methodology.
A total of 23 neurodevelopmental outcomes were examined.
TAKEAWAY:
Most neurodevelopmental outcomes (19/23) showed no association with antenatal corticosteroid administration.
Children exposed to antenatal corticosteroids showed modestly decreased nonverbal intelligence scores (standardized mean difference [SMD], -0.16; 95% CI, -0.32 to -0.01) and visual memory scores (SMD, -0.29; 95% CI, -0.51 to -0.07).
Randomized trial follow-ups indicated a nonsignificant trend toward protective effects for general development, while quasi-experimental studies suggested increased risk.
Studies with low or moderate risk for bias revealed no association between antenatal corticosteroid administration and adverse child neurodevelopment.
IN PRACTICE:
'Among studies with low or moderate risk of bias, we found no association between antenatal corticosteroid administration and adverse child neurodevelopment. There is no consistent evidence that antenatal corticosteroids are associated with an increased risk of impaired childhood neurodevelopment among studies with a strong design to control for confounding,' wrote the authors of the study.
SOURCE:
The study was led by Jessica Liauw, MD, Department of Obstetrics and Gynaecology at University of British Columbia in Vancouver, Canada. It was published online in Obstetrics & Gynecology .
LIMITATIONS:
Most randomized controlled trial follow-up studies had significant losses to follow-up, with the two largest studies experiencing 66% and 40% attrition rates, leading to potential selection bias. Researchers noted that few studies specifically investigated the effects of antenatal corticosteroids administered in the late preterm period, limiting understanding of the timing-specific impacts. Additionally, the authors acknowledged that sibling-comparison studies did not adequately control for differences in pregnancy complications that determine why corticosteroids were administered in one pregnancy but not another.
DISCLOSURES:
The study was supported by a project grant from the Canadian Institutes of Health Research. Liauw received a Michael Smith BC Health Professional Investigator Award, and Jennifer Hutcheon, PhD, was supported by a Canada Research Chair in perinatal population health. The funders had no role in the research design or manuscript submission decisions. The authors reported no potential conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
UBS Raised the Firm's PT on LifeStance Health Group (LFST), Kept a Buy Rating
LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the . On August 8, UBS raised the firm's price target for LifeStance Health Group, Inc. (NASDAQ:LFST) from $8.50 to $9, while maintaining a Buy rating on the stock. The increased price target follows the company's fiscal second-quarter earnings release. The company exceeded both revenue and earnings estimates during the quarter. LifeStance Health Group, Inc. (NASDAQ:LFST) posted a revenue of $345.31 million, reflecting a 10.56% year-over-year growth and ahead of estimates by $58,730. Moreover, the EPS of negative $0.01 also beat the analyst consensus by $0.02. A close-up of a healthcare professional studying a computer screen with data while consulting with a patient. Management noted that they increased the number of clinicians providing care by 11% year-over-year, which led to a 12% increase in visit volumes during the quarter. Looking ahead, management has reaffirmed its full-year revenue guidance in the range of $1.40 billion to $1.44 billion. LifeStance Health Group, Inc. (NASDAQ:LFST) is a reimagining mental health company that provides both virtual and in-person mental healthcare for children, adolescents, and adults. While we acknowledge the potential of LFST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
CEO Coaching International Announces AffordaCare as New Diamond Strategic Partner to Help CEOs Strengthen People Strategy
MIAMI, Aug. 11, 2025 /PRNewswire/ -- CEO Coaching International, the leading CEO coaching firm for growth-focused CEOs and entrepreneurs globally, proudly welcomes AffordaCare Insurance as its newest Diamond Strategic Partner. This powerful partnership unites two firms committed to helping CEOs drive growth by building highly engaged teams. Founded in 2011, AffordaCare Insurance is nationally recognized for transforming the employee benefits landscape with its flagship Champion Health Plan (CHAMP). The CHAMP Plan wraps around existing health coverage to give employees and their families expanded access to essential care, like primary care visits, mental health support, and telemedicine, with $0 copays and no disruption to current plans. "Our CEO clients are always looking for effective ways to attract and retain top talent," said Randy Dewey, CEO of CEO Coaching International. "With the CHAMP Plan, AffordaCare provides a practical solution that strengthens benefits without adding cost or complexity for CEOs. Investing in your people is a proven way to build a high-performance company." As a Diamond Strategic Partner, AffordaCare will bring added value to the CEO Coaching International community through exclusive client workshops, strategic benefits consultations, thought leadership content, and participation in high-impact virtual and in-person events, including the annual Make BIG Happen Summit. "We're proud to partner with CEO Coaching International to help growth-minded CEOs reimagine what's possible with their benefits strategy," said Steven Guilfoile, CEO of AffordaCare Insurance. "Too many CEOs are facing rising healthcare costs, limited benefit options, and talent retention challenges. The CHAMP Plan offers a win-win: better benefits, happier employees, and improved margins." AffordaCare's simple, scalable approach has already attracted partnerships with some of the largest government sectors, public and private companies in the United States, reinforcing its position as a disruptive force in modern employee benefits. To learn more about AffordaCare Insurance and how the Champion Health Plan can support your growth goals, visit To explore the Strategic Partner Program at CEO Coaching International, visit About CEO Coaching International CEO Coaching International works with CEOs and their leadership teams to achieve extraordinary results quarter after quarter, year after year. Known globally for its success in coaching growth-focused entrepreneurs to meaningful exits, the firm has coached more than 1,500+ CEOs and entrepreneurs across 100+ industries and 60 countries. Its coaches—former CEOs, presidents, and executives—have led businesses ranging from startups to over $10 billion, driving double-digit sales and profit growth, many culminating in eight, nine, or ten-figure exits. Companies that have worked with CEO Coaching International for two years or more have achieved an average revenue CAGR of 25.9% (2.6X the U.S. average) and an average EBITDA CAGR of 39.2% (more than 4X the U.S. average). Discover how coaching can transform your leadership journey at View original content to download multimedia: SOURCE CEO Coaching International Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
2 hours ago
- Medscape
Patients With GI Issues? Natural Remedies May Give Relief
Almost two thirds of Americans are burdened by gastrointestinal (GI) symptoms like heartburn, abdominal pain, bloating, diarrhea, and constipation. And for almost 40% of Americans, uncomfortable bowel symptoms are bad enough that they forgo routine activities such as exercising or spending time with their families. Medications, both over the counter and prescription, targeting GI conditions are plentiful. Yet more and more patients are requesting natural routes to relief, doctors told Medscape Medical News , and it's likely your patients are, too. Here are some examples from doctors on how they've integrated natural remedies into their practice for specific common complaints. Some remedies have published research to back them up, while others are anecdotal, but backed by patients and doctors reporting that they do work. Irritable Bowel Syndrome (IBS) For patients with IBS, Priyanka Hennis, MD, MS, family medicine physician in Phoenix, prescribes a diet low in fermentable oligosaccharides, disaccharide, monosaccharide, and polyols (FODMAP). The American Gastroenterological Association also recommends dietary and lifestyle modification first, including a low-FODMAP diet. The American College of Gastroenterology provides further details on what a low-FODMAP diet is, how it works, and examples of high- and low-FODMAP foods. Wheat, apples, and milk are high in FODMAPS, for instance; oatmeal, broccoli, and eggs are low. A low-FODMAP diet reduces certain difficulties in digesting carbohydrates. In one study comparing a low-FODMAP diet plus traditional IBS dietary advice, a low-carbohydrate diet with high in protein and fat, and medical treatment based on the predominant symptom, researchers found that more patients in the dietary intervention groups improved. Seventy-six percentage of patients in the low-FODMAP group reduced their IBS symptoms severity score by 50 points or more, as did 71% of those in the low-carbohydrate group, but just 58% of the medication group did so. 'Dietary interventions might be considered as an initial treatment for patients with IBS,' the researchers concluded. And if your patient equates IBS with irritable bowel disease, that's a common myth that's ripe for debunking, and it's easy to explain the difference, said Omar S. Khokhar, MD, board-certified gastroenterologist at OSF Healthcare, St. Joseph Medical Center, Bloomington, Illinois. 'IBS by definition is a syndrome, a constellation of symptoms, for which we can't find an organic pathology. IBD [inflammatory bowel disease] is a completely different phenomenon, where there is active inflammation inside your GI tract, causing symptoms, and physiological changes.' The disruption of the gut microbiota, or dysbiosis, is thought to play a role in IBS, Khokhar said, and recent research agreed. The goal to provide relief is restoring the microbiota by such measures as dietary changes. For patients with constipation-predominant IBS, Hennis also recommended slow, deep breathing to improve symptoms. In one study comparing patients who conducted deep breathing exercises and control individuals, the intervention group had improved symptoms, with a higher desire to defecate, improvements in stool consistency, and in weekly bowel movement frequencies. Constipation While psyllium and prunes are old standbys for chronic constipation, kiwifruit also has some solid research behind it. Researchers randomly assigned 75 people with chronic constipation to eat either two green kiwifruits, 100 g of prunes, or 12 g of psyllium each day for 4 weeks. Improvements in bowel movement frequency were similar for all three groups, but stool consistency improved more with the kiwi and the prunes. Those in the kiwi group had improvement in bloating. People also preferred the kiwi treatment. Try a constipation smoothie, suggested Erin Toto, MD, assistant professor of gastroenterology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia. The recipe is from the University of Michigan Bowel Control Program and has fresh fruit, kefir, and ice. The age-old advice to increase fiber still holds, said Cynthia Odogwu, MD, family medicine physician in Bowie, Maryland. The Dietary Guidelines for Americans recommend fiber intakes based on age and sex and offer a chart of fiber content of common foods. Odogwu suggested 25-35 g a day for adults. It's crucial to drink water with fiber, Khokhar said. Along with taking in 30 g of fiber daily, he tells patients to drink 64 oz of water. Gastroesophageal Reflux Disease (GERD) For GERD, try aloe vera, said Chrissie Ott, MD, an integrative pediatrician and internal medicine physician in Portland, Oregon. In a study, Chinese researchers reported that aloe vera syrup was safe and effective, and it reduced the frequencies of eight main GERD symptoms: heartburn, food regurgitation, flatulence, belching, dysphagia, nausea, vomiting, and acid regurgitation. 'And if there is inflammation in the gut, it's an easy way to soothe things quickly,' Ott said. Apple cider vinegar is another GERD remedy, Khokhar said. He advised about a tablespoon mixed with 8 oz of water. 'Drink it anytime during the day.' Lifestyle adjustments — including weight loss if needed, raising the head of the bed and reducing intake of caffeine and alcohol — can greatly reduce GERD symptoms, experts concurred. Khokhar tells patients that many GI maladies are also a result of diet and warns against such practices as eating a huge plate of pasta before bedtime. Excess Gas Fermented foods, such as sauerkraut and apple cider vinegar, can significantly impact the microbiome and can help patients with excess gas and small intestinal bacterial overgrowth, Ott said. Published research backs her up on the impact of fermented foods on the microbiome, with researchers finding fermented foods 'should be considered an important element of the human diet.' She suggests her patients with excess gas to try her nonalcoholic 'cocktail' — a mix of 1 tablespoon of apple cider vinegar, flavored or unflavored bubbly water, and a slice of lemon. Another option is to spoon a few tablespoons of sauerkraut on the side of a dish. Khokhar reminds patients: 'Gas is a normal, healthy byproduct of the digestive process.' But if it becomes an issue for them, he advises taking stock of whether they are eating high amounts of foods known to produce gas, such as beans, cabbage, broccoli, yogurt, and sugary drinks. Nausea and Vomiting For nausea and vomiting, try ginger, said Troy Alexander-El, MD, a primary care physician in Portland, Oregon. While some researchers conclude it is a safe botanical option, they also note that the quality of published evidence should be increased. Alexander-El said she adds ginger to dishes while cooking. She buys ginger slices or ginger cubes in the frozen food section and adds a cube when cooking dishes like broccoli. 'It can also help with gas.' Diarrhea Peppermint oil can help the diarrhea and the cramping that often accompanies it, Khokhar said. He suggested taking one or two capsules of over-the-counter peppermint oil one to three times a day. Research is mixed, with some research finding it helped improve IBS symptoms (such as diarrhea) but not significantly better than placebo. A meta-analysis found it effective for adults with IBS symptoms, but researchers called for more research. Gut Shy? While GI issues are common, patients are often reluctant to broach the subject with their physicians. The American Gastroenterological Association found people with GI issues would rather discuss politics or reveal their weight than talk about GI distress with their doctors. To turn that reluctance around, the society launched its 'Trust Your Gut' campaign to help people open up and get help.
